279 related articles for article (PubMed ID: 20216310)
21. Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism.
ALJohani AM; Syed DN; Ntambi JM
Trends Endocrinol Metab; 2017 Dec; 28(12):831-842. PubMed ID: 29089222
[TBL] [Abstract][Full Text] [Related]
22. SCD1 inhibition during 3T3-L1 adipocyte differentiation remodels triacylglycerol, diacylglycerol and phospholipid fatty acid composition.
Ralston JC; Mutch DM
Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():29-37. PubMed ID: 25959085
[TBL] [Abstract][Full Text] [Related]
23. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.
Sun S; Zhang Z; Pokrovskaia N; Chowdhury S; Jia Q; Chang E; Khakh K; Kwan R; McLaren DG; Radomski CC; Ratkay LG; Fu J; Dales NA; Winther MD
Bioorg Med Chem; 2015 Feb; 23(3):455-65. PubMed ID: 25555732
[TBL] [Abstract][Full Text] [Related]
24. Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).
Voss MD; Zoller G; Matter H; Herling AW; Biemer-Daub G; Pfenninger A; Haag-Diergarten S; Keil S; Kohlmann M; Schmidts HL
Eur J Pharmacol; 2013 May; 707(1-3):140-6. PubMed ID: 23524088
[TBL] [Abstract][Full Text] [Related]
25. Monounsaturated Fatty Acids in Obesity-Related Inflammation.
Ravaut G; Légiot A; Bergeron KF; Mounier C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396940
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
27. Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation.
Dalla Valle A; Vertongen P; Spruyt D; Lechanteur J; Suain V; Gaspard N; Brion JP; Gangji V; Rasschaert J
Front Endocrinol (Lausanne); 2019; 10():726. PubMed ID: 31708874
[TBL] [Abstract][Full Text] [Related]
28. Sequential Dynamics of Stearoyl-CoA Desaturase-1(SCD1)/Ligand Binding and Unbinding Mechanism: A Computational Study.
Petroff AB; Weir RL; Yates CR; Ng JD; Baudry J
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680068
[TBL] [Abstract][Full Text] [Related]
29. Structure-based virtual screening of natural products as potential stearoyl-coenzyme a desaturase 1 (SCD1) inhibitors.
Huang Y; Wang H; Wang H; Wen R; Geng X; Huang T; Shi J; Wang X; Wang J
Comput Biol Chem; 2020 Jun; 86():107263. PubMed ID: 32315834
[TBL] [Abstract][Full Text] [Related]
30. Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase.
Dobrzyn P; Dobrzyn A
Expert Opin Ther Pat; 2010 Jun; 20(6):849-53. PubMed ID: 20205608
[TBL] [Abstract][Full Text] [Related]
31. An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 - 2013).
Powell DA
Expert Opin Ther Pat; 2014 Feb; 24(2):155-75. PubMed ID: 24251719
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
34. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis.
Sen U; Coleman C; Sen T
Trends Cancer; 2023 Jun; 9(6):480-489. PubMed ID: 37029018
[TBL] [Abstract][Full Text] [Related]
35. Protein engineering: Regulatory perspectives of stearoyl CoA desaturase.
Kamal S; Saleem A; Rehman S; Bibi I; Iqbal HMN
Int J Biol Macromol; 2018 Jul; 114():692-699. PubMed ID: 29605251
[TBL] [Abstract][Full Text] [Related]
36. Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases.
Peláez R; Pariente A; Pérez-Sala Á; Larráyoz IM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936134
[TBL] [Abstract][Full Text] [Related]
37. Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors.
Ramtohul YK; Powell D; Leclerc JP; Leger S; Oballa R; Black C; Isabel E; Li CS; Crane S; Robichaud J; Guay J; Guiral S; Zhang L; Huang Z
Bioorg Med Chem Lett; 2011 Oct; 21(19):5692-6. PubMed ID: 21871798
[TBL] [Abstract][Full Text] [Related]
38. Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.
Sinha RA; Singh BK; Zhou J; Xie S; Farah BL; Lesmana R; Ohba K; Tripathi M; Ghosh S; Hollenberg AN; Yen PM
Autophagy; 2017 Jan; 13(1):169-186. PubMed ID: 27846372
[TBL] [Abstract][Full Text] [Related]
39. Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease.
Zhang Z; Dales NA; Winther MD
J Med Chem; 2014 Jun; 57(12):5039-56. PubMed ID: 24295027
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
